Treatment Recommendations for Low Transphincteric Fistula in Patients with Limited Life Expectancy

Introduction to Fistulotomy

The American Gastroenterological Association recommends fistulotomy as the definitive treatment for low transphincteric fistula in patients with a limited life expectancy, prioritizing complete healing over continence preservation, with a near 100% healing rate 1, 2

Fistulotomy achieves a high success rate, with minimal risk of recurrence, and complete healing typically occurs within weeks to months, making it a suitable option for patients with a limited life expectancy 1, 2, 3
The standard concern about sphincter division causing incontinence becomes irrelevant when the patient will be diaper-dependent regardless within the same timeframe needed for healing, according to the European Crohn's and Colitis Organisation (ECCO) guidelines 1

Sphincter-preserving procedures like LIFT or advancement flaps offer lower success rates, ranging from 53-77% and 64%, respectively, and carry significant disadvantages, including higher recurrence rates and requirement for re-intervention 2, 4
The LIFT procedure has a true recurrence rate of up to 21% with adequate follow-up, and a median time to failure of 4 months when it occurs, as reported by the American Society of Colon and Rectal Surgeons (ASCRS) 4

The execution of fistulotomy should involve laying open the primary tract and any side branches completely, with a thorough examination under anesthesia to accurately define anatomy, as recommended by the Society of Surgery of the Alimentary Tract (SSAT) 2, 3

Fistulotomy is absolutely contraindicated in patients with active proctitis or rectosigmoid inflammation, anterior fistula in female patients, or evidence of Crohn's disease with a high disease activity index, according to the Crohn's and Colitis Foundation of America (CCFA) 3

The recommendation prioritizes complete healing and symptom resolution over continence preservation because ongoing fistula drainage significantly impairs quality of life, and failed sphincter-preserving procedures would consume precious remaining time, as emphasized by the American College of Gastroenterology (ACG) 1, 2, 5, 6

The 2024 ECCO guidelines emphasize that treatment should be "on a treat to patient goal basis", and in this case, the goal is complete healing within 2 years, not continence preservation for decades, highlighting the importance of individualized treatment plans, as recommended by the European Society of Coloproctology (ESCP) 1, 3, 5